INVEST HEALTH INNOVATION
Millions of people around the world are turning to Ozempic to help them lose weight, but its effects are being felt far beyond the bathroom scales.
The drug's ability to help people shed extra kilos has given a huge boost to the economy of Denmark, where it is produced; is shaving billions of dollars off the value of companies that stand to lose out from a thinner population; and could have farreaching effects on the economies of Australia and other nations where obesity is a growing problem.
Ozempic was approved for use as a diabetes treatment. It and similar drugs contain semaglutide – it mimics the action of a naturally occurring hormone called GLP-1, which helps the pancreas produce insulin and, in turn, works to manage type 2 diabetes.
Although not designed to be a weight-loss medication, it has been found
